SYNAPTICON AND GENERATIVE BIONICS FORGE A PARTNERSHIP FOR LEADING-EDGE EUROPEAN ACTUATOR TECHNOLOGY
The German-Italian partnership aims to keep the critical drive system of humanoid robots within Europe, from development through to integration.
Schönaich, Germany, June 16, 2026 – Synapticon GmbH, a provider of safety-certified drive technology, and Generative Bionics, an Italian developer of humanoid robots, have announced a strategic partnership. Their shared goal is to establish a resilient supply chain for key humanoid robot technologies that remains under European control. The collaboration is intended to ensure that the core drive system for Physical AI is developed, manufactured, certified, and integrated in Europe.
STRENGTHENING EUROPE'S TECHNOLOGICAL SOVEREIGNTY
Humanoid robotics is currently making rapid inroads from research laboratories into industrial and service applications. As this trend continues, control over the underlying technology stack is becoming increasingly important from a strategic perspective. The location where these technologies are developed and manufactured is also crucial. Both companies are convinced that Europe must strengthen its technological sovereignty over the hardware and software stack of Physical AI. At the same time, it is essential to reduce dependence on external supply chains for components that determine a robot’s performance, safety, and certification requirements.
The drive system is of central importance for any humanoid platform. It encompasses the integrated interaction of motors, servo drives, encoders, functional safety, and motion control software. It is this combination that enables precise movements and safe operation in close proximity to people.
"At Synapticon, our mission is to enable progress in robotics—and few applications demand movement and safety as much as humanoid robots. Generative Bionics is building one of Europe’s most ambitious humanoid platforms, and that is exactly where our integrated actuator technology belongs," explains Simon Fischinger, CEO of Synapticon.
At the same time, this is precisely where significant supply chain risks exist. European programs often rely on external suppliers for critical electromechanical components. Synapticon and Generative Bionics are therefore integrating this level into a jointly managed European framework. The aim is to turn a structural weakness into a competitive advantage. This is in line with the objectives of the European Chips Act and the Critical Raw Materials Act.
"Europe faces a clear challenge regarding its technological sovereignty in the fields of physical AI and humanoid robotics. This is not about closed or isolated supply chains. The key technologies for humanoid robots must be resilient to geopolitical fluctuations and supply chain disruptions. At the same time, they must meet safety and certification requirements. The drive system is of fundamental importance here. This is where movement, safety, reliability, and certification requirements converge," says Daniele Pucci, CEO of Generative Bionics.
THREE PILLARS OF COOPERATION
First, the partners are establishing a supply chain for the drive system of Generative Bionics’ humanoid platform that is secured within the EU. Final assembly, calibration, and safety testing are to take place within the European Economic Area, primarily in Germany. In addition, the plan includes pre-qualified European alternatives, safety stocks held within the EU, and measures to ensure the traceability of critical components.
Second, the partners are jointly developing custom drive units for Generative Bionics. These units integrate motors, servo drives, encoders, firmware, and functional safety features. The units are tailored to the mechanical, thermal, and control requirements of Generative Bionics’ humanoid architecture.
Third, the companies are jointly designing an integrated safety architecture for humanoid robots. This ranges from safe motion control and person recognition to behavioral monitoring of AI-driven robotic systems. The partners are building on Synapticon’s POSITRON Safety Platform. Further development will be guided by the international standards currently being developed.
"Together, we cover the entire drive system—motor, servo controller, encoder, firmware, and certified functional safety. The components are developed as a single system and designed to scale from prototyping to series production in Europe. Keeping this level of development in Europe does not mean isolation. It’s about control, speed, and trust—where they matter most. We are proud to bring our software-first drive technology and our POSITRON Safety platform to the heart of Generative Bionics’ robots,” adds Simon Fischinger.
RESILIENCE FROM THE START
The partnership is based on the principle that resilience must be taken into account from the very beginning. It must not be added only under the pressure of a disruption. Accordingly, measures to ensure technological sovereignty will therefore be included in the partners’ binding agreements. These include pre-qualified European alternatives that can be deployed in the event of a disruption, as well as safety stocks of critical components stored within the EU.
In addition, companies intend to maintain confidential records to ensure traceability. These records should be sufficient to verify the European origin, manufacturing location, and qualification status of critical components, subject to appropriate access restrictions.
"We are delighted about our partnership with Synapticon. Our shared goal is to build a sovereign and resilient European technology stack for humanoid robot propulsion systems. This partnership is not just about components. It is about securing one of the core areas of Physical AI in Europe and achieving technological sovereignty on an industrial scale," emphasizes Daniele Pucci.
STRATEGIC ROLES AND JOINT INDUSTRIALIZATION
Under this agreement, both companies grant each other strategic status. Synapticon will serve as a strategic European supplier for the agreed scope of drive technology for Generative Bionics’ humanoid platform. As a strategic European customer, Generative Bionics will receive preferential access to production capacity secured within the EU. This is subject to mutually agreed commercial, technical, and operational terms.
Even before the product becomes widely available on the market, the partners are also collaborating on a series of actuators from Synapticon. The series is designed for high-volume production modeled after the automotive industry. Generative Bionics will provide structured feedback on the series to support its industrialization and ongoing development.
ABOUT SYNAPTICON
Synapticon develops and manufactures integrated motion control hardware and software for robotics and industrial automation—with a clear focus on humanoid robotics and embodied AI. Founded in 2012 and headquartered in Schönaich near Stuttgart, with offices in Silicon Valley, Shanghai, Shenzhen, and Belgrade, the company is the only one that develops servo drives based on the software-first principle. The product portfolio includes the SOMANET™ servo drive families, ACTILINK actuators for robot joints, the MOTORCORTEX motion software, and the POSITRON Safety AI platform, certified to SIL3 PLe. Synapticon is a strategic partner of the maxon Group. For more information, visit www.synapticon.com.
Media Contact Synapticon
Jan Kaiser, Head of Marketing
Synapticon | Integrated Motion
Email: jkaiser@synapticon.com
Mobile: +49 171 89 44 085
Fax: +49 7031 30 478-99
ABOUT GENERATIVE BIONICS
Generative Bionics is an Italian deep-tech company specializing in the development of humanoid robots based on Physical AI. Based in Genoa, the company combines advanced robotics, artificial intelligence, and design to create humanoid platforms engineered for safe and reliable operation in complex industrial environments. The human element is at the heart of the development process.
Generative Bionics' solutions help improve safety, ergonomics, and operational continuity. They can be integrated into existing production processes without requiring any special infrastructure. For more information, visit gbionics.ai.
Media Contact: Generative Bionics
Press Office
Tel. +39 331 978 3149
press@gbionics.ai
